HiNature, the Korean owner of the vegan skincare brand Purito Seoul, is a K-beauty company almost no one in Korea has heard of. Roughly 90% of its sales come from Europe and the rest from the Americas, while every unit is made in Korea. Corstone Asia, the Korean private equity firm that bought 100% of the company in November 2022 for KRW 37.3 billion (approx. USD 27 million at USD/KRW 1,358, Sept. 2, 2026 close), is now running a sale against a market ask reported at around 10x EBITDA, or an enterprise value of KRW 200 billion or more.
The headline arithmetic invites the wrong question. The structural question is not whether HiNature is a good company, but who carries the risk that the latest year is a peak rather than a run-rate, and in what form.
Corstone Asia answered its half before going to market, by taking KRW 20 billion in dividends out of the company. The buyer has not, and its best defense is to split the price rather than cut it.
The Deal
HiNature is a Korea-headquartered cosmetics company whose brand was validated abroad before it was known at home. Corstone Asia acquired it through its second blind-pool fund, a KRW 220 billion vehicle raised in 2018, buying out the founder and the other shareholders in full. No acquisition financing was used.
- Entry: 100% stake for KRW 37.3 billion in November 2022, all equity, no acquisition debt.
- At entry: revenue of KRW 12.5 billion and operating profit of KRW 5.2 billion, an operating margin above 40%.
- Growth: revenue of KRW 12.5 billion, then 20 billion, 34 billion and 68.4 billion in the latest fiscal year (+101% YoY); operating profit of KRW 20.4 billion (+104%), with margins holding near 30%.
- Distributions: KRW 10 billion in dividends in each of 2023 and 2024, KRW 20 billion in total.
- Process: sale under way; the ask is reportedly around 10x EBITDA, implying an EV of KRW 200 billion or more. Bidders and terms are not disclosed.
The entry economics matter as much as the growth curve: a business clearing a 40% margin on KRW 12.5 billion of revenue had proven its unit economics before it had scale. Corstone Asia did not buy a turnaround; it bought a working machine and fed it time.
Structure Breakdown
Start with the seller’s cost basis. Of KRW 37.3 billion invested, KRW 20 billion, more than half, came back as dividends before any exit. That leaves roughly KRW 17.3 billion of book exposure against a business now producing about KRW 20 billion of operating profit a year.
On those numbers, even a one- to two-year delay in the sale would let dividends alone return the remaining principal. A seller who cannot lose its principal is not negotiating to get out. It is negotiating to get more, and that, rather than the growth story, is what holds the 10x ask in place.
Strip out the vocabulary of vegan and clean beauty and the asset is narrower. Europe, guarded by regulatory registration and the slow accumulation of consumer trust, has been one of the hardest markets for Korean cosmetics, and even Amorepacific has struggled to penetrate it. HiNature crossed both gates with time and reviews rather than capital, so a buyer is paying for a Western online trust pool: years of reviews, search presence and repurchase data.
The market has priced this asset class before. Ferenbell, owner of Some By Mi with about 95% of sales in Southeast Asia, was sold to JKL Partners in 2021 for KRW 260 billion and is reportedly back in a sale process. Beauty of Joseon broke out on US Amazon before becoming a cornerstone of Goodai Global, a multi-brand platform with annual revenue in the KRW 1.4 trillion range, and Amorepacific paid KRW 935.1 billion for COSRX.
The open question is the character of KRW 68.4 billion. After a five-fold rise in three years, the latest print could be a structural level or a crest of the K-beauty tailwind, and no diligence fully resolves which. The trust pool also sits on third-party online channels, where a fee change, an algorithm update or a single efficacy controversy can move a quarter.
The Governing Logic
Architects build structures not to make money but to avoid losing it. Here, the two sides work from entirely different blueprints.
The Seller’s Sealed Downside
Corstone Asia’s downside defense was finished before the process began: an unlevered entry, then two years of dividends. Those two unglamorous decisions now set the slope of the table.
The structure carries one clock. The vehicle is a 2018-vintage blind fund, and fund documents, not market conditions, set the harvest deadline. The equilibrium follows from that: the seller is patient on price but pressed on time, while the buyer is patient on time but pressed to justify price.
The Buyer’s Downside Protection
The buyer has a single enemy: buying the peak. If the latest numbers are structural, 10x may be cheap; if they are a crest, 7x is expensive. A rational buyer therefore splits the price rather than cutting it, deferring an estimated 20–30% of consideration into an earn-out (deferred consideration paid only if post-closing results arrive) over the next two fiscal years.
This is Proof-Deferred Pricing. The instrument is not a discount but a transfer of the burden of proof: if the numbers are real, the seller collects in full, and the normalized-earnings argument leaves the contract. It also keeps the seller financially interested in the truth of the numbers after closing. A PE seller approaching fund wind-down may well resist it, and that resistance is information in itself.
The second line is tail-risk transfer. Once the selling fund liquidates there is no pocket left to claim against, so W&I insurance (warranty-and-indemnity cover placed with an insurer) should carry financial, tax and compliance warranties, while identified risks, such as a renewed efficacy controversy or an overseas regulatory breach, sit in special indemnities backed by escrow.
Leverage follows the same rule. With about 90% of revenue exposed to currency and platform policy, the desk’s read caps acquisition debt at roughly 2x EBITDA; beyond that is a design flaw, not ambition.
What Must Be True
1. The earnings are cash, not channel inventory. Ferenbell, the eldest sibling in this asset class, was reportedly flagged in its sale process for operating cash flow running in reverse as revenue neared KRW 100 billion, with receivables and inventory outpacing sales. HiNature’s doubling year faces the same questionnaire: sell-in versus sell-through, and where returns and rebates are booked. Falsifier: operating cash flow trailing operating profit, or receivables and inventory growing faster than revenue.
2. Growth stays above the re-rating threshold. If growth settles into the 30% range, the business re-rates from a growth multiple to a consumer-staples multiple, and earnings estimates and the multiple compress at the same time. Falsifier: the next fiscal year’s revenue growth landing near 30%.
3. The trust pool survives risks the company does not control. Single-brand concentration, platform dependence, US tariffs and tighter EU ingredient and packaging rules are manageable alone; stacked, they are not. Expansion in the Americas accounts for about half of the growth option in the exit narrative, and a competitor’s quality scandal can drain category trust from a single-brand company first. Falsifier: a platform fee or algorithm change moving a quarter’s revenue by double digits, which would also turn the earn-out from a protection into a dispute.
These risks call each other. Slowing growth breaks the narrative, the narrative’s collapse thins the strategic buyer list, fewer buyers compress the multiple, and a delayed exit starves brand investment, which slows growth again. A KRW 200 billion valuation would not fail by crash, but by a quiet re-rating as this chain completes one turn.
The Architect’s Takeaway
The point is not to admire the deal but to move its logic onto your own board. It hands over three blueprints.
Select the gated market. HiNature skipped the rank war in a saturated home market and stood first at a gate no one else queued for. If you were building your own deal room, you would avoid competing for commentary on the domestic mega-deals everyone covers and dig first into niches with a high verification cost, such as Southeast Asian mid-cap deals or European indie-brand M&A. Trust built outside can be re-imported home later.
Seal the downside during the hold. Corstone Asia is relaxed at the table because cash flow returned half its principal before the exit. Do not stake all recovery on a single exit event; write upfront fees, subscription cash flow and interim settlement clauses into the contract. For a community, the annual membership is the dividend; for a content business, the fixed sponsorship is. Structure buys time before it buys returns.
Transfer the burden of proof. A freelancer can pair a fixed fee with performance-linked upside; a joint project can move from trusting the partner’s forecast to milestone-based staged commitment. If the counterparty’s numbers are real, it has no reason to refuse; if it refuses, the refusal is the diligence result. Capital sets the scale; structure sets the outcome.
Syndicate’s Note
HiNature is less a test of K-beauty valuations than a test of sequencing. Corstone Asia completed its no-loss structure first and is now selling a peak it no longer needs to defend. The winner of this deal will not be the side that names the higher number, but the side that finishes its no-loss structure first.
The buyer’s task is to buy the structure, not the peak: split the price, insure the tail, keep the leverage light. The 2018 fund clock is the one variable that can still move the seller.
House Verdict: TRACK. The sale is live, and its signed terms will test this read directly. Verdicts classify structural learning value, not investment merit. Falsifier: if HiNature signs at or above 10x EBITDA with the full consideration paid in cash at closing and no earn-out, escrow or other deferred element, the buyer has accepted the latest year as run-rate and the peak risk was never priced.
FAQ
What is an earn-out in private equity M&A?
An earn-out is a portion of the purchase price paid only if the target meets agreed performance targets after closing. It is used when buyer and seller disagree on whether recent earnings will last, and it makes the seller prove its own forecast.
Who owns Purito Seoul, and is it for sale?
Purito Seoul is operated by HiNature, which Corstone Asia has owned outright since November 2022 after a KRW 37.3 billion acquisition. Per market reports, a sale is under way at an ask around 10x EBITDA; buyer and terms were undisclosed as of September 2026.
Why do overseas-first K-beauty brands attract acquirers?
They carry demand already proven in markets that are slow and costly to enter, as COSRX (KRW 935.1 billion to Amorepacific) and Ferenbell (KRW 260 billion to JKL Partners) showed. The offsetting risks are single-brand concentration, platform dependence and the chance that recent growth marks a peak.
This article is for informational purposes only and does not constitute investment advice, an offer, or a solicitation. Figures are based on public reports and may be estimates.
For more structural insights and deep-dive video breakdowns, visit Structure Syndicate on YouTube.